Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

Phase 4

• Conditions: Bladder Cancer
• Interventions: Drug: Tamsulosin; Procedure: Transurethral Resection

• Registration Number: NCT02443844
• Lead Sponsor: Diskapi Teaching and Research Hospital

Brief Summary

The purpose of this study is to compare medical and surgical treatments of benign prostate hyperplasia in patients who have non muscle invasive bladder cancer for tumour recurrence and progression.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-02
• Study First Submitted: 2015-04-28
• Status Verified: 2015-05
• Study First Submitted QC: 2015-05-11
• Last Update Submitted: 2015-05-11
• Study First Posted: 2015-05-14
• Last Update Posted: 2015-05-14
• Primary Completion: 2018-02
• Study Completion: 2020-02

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

• Patients who have non muscle invasive bladder cancer male patients patients between 40-80 years old

Exclusion Criteria

• Patients who have previous prostate surgery Patients who have muscle invasive bladder cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
First group	Tamsulosin	Patients taken tamsulosin for benign prostate hyperplasia who have non muscle invasive bladder cancer
Second Group	Transurethral Resection	Patients taken transurethral resection prostatectomy for benign prostate hyperplasia who have non muscle invasive bladder cancer

Primary Outcome Measures

Name	Time	Method
Recurrence	3 years	Bladder cancer recurrence rate

Secondary Outcome Measures

Name	Time	Method
Progression	3 years	Bladder cancer progression rate

Trial Locations

Locations (1)

Turkish Ministry of Health Dıskapı Yıldırım Beyazıt Training and Research Hospital; 🇹🇷 Ankara, Turkey